Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Background Almost half of adults worldwide now live with excess body fat, a figure projected to climb to 54% by 2035, and it drives type 2 diabetes, hypertension, dyslipidemia, osteoarthritis, and mood disorders
Orforglipron significantly improved those parameters compared with controls
Jagdale AD, et al
doi: 10.3389/fphar.2024.1478170 Received 09 August 2024 Accepted 07 October 2024 Published 17 October 2024 Volume 15 - 2024 Edited by Nageswaran Sivalingam, RM Institute of Science and Technology, India Reviewed by Kusmardi Kusmardi, University of Indonesia, Indonesia Arumugam Suriyam Nagappan, University of Madras, India Updates Copyright 2024 Gan, Shi, Liu, Ding, Qiu and Luo
